Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study

Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study

We aimed to explore the efficacy of rechallenge after first-line immunotherapy in advanced gastric cancer (AGC) and to analyze the factors affecting prognosis based on clinical characteristics. Eighty-five AGC patients who underwent rechallenged after the failure of first-line treatment with immune...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengya Guo, Wenhui Zhao, Yue Chen, Dan Zou, Weiwei Peng, Huanhuan Sha, Guoren Zhou, Ying Fang, Bo Shen
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Advanced gastric cancer
immune checkpoint inhibitors
rechallenge
efficacy
safety
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2423479
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items